论文部分内容阅读
目的观察雾化吸入布地奈德治疗小儿急性喉—支气管炎的临床疗效。方法选取2013年10月-2015年7月医院接收小儿急性喉—支气管炎患者70例,按照住院时间顺序依次编号,随机分为对照组和试验组各35例,对照组接受静脉注射地塞米松治疗,试验组接受雾化吸入布地奈德治疗,比较2组患者治疗后的临床总效率及不良症状消失所花费的时间对比。结果试验组总有效率为88.57%明显高于对照组的60.00%,差异有统计学意义(P<0.05)。试验组高温消失时间、呼吸困难消失时间、声嘶消失时间明显短于对照组,差异均有统计学意义(P<0.05)。结论应用雾化吸布地奈德治疗小儿急性喉—支气管炎临床疗效高,患者的治疗疗程明显缩短,病情恢复较快,临床效果更佳。
Objective To observe the clinical efficacy of inhaled budesonide in the treatment of acute laryngo-bronchitis in children. Methods Seventy patients admitted to our hospital from October 2013 to July 2015 were enrolled in this study. The patients were randomly divided into control group and experimental group with 35 cases in each group. The control group received intravenous dexamethasone Treatment, the experimental group received inhaled budesonide treatment, compared the two groups of patients after treatment, the total clinical efficiency and adverse symptoms disappeared time spent comparing. Results The total effective rate of the experimental group was 88.57%, which was significantly higher than that of the control group (60.00%), the difference was statistically significant (P <0.05). The disappearance time of hyperthermia, disappearance of dyspnea and disappearance of hoarseness in the experimental group were significantly shorter than those in the control group, with significant differences (P <0.05). Conclusion The application of atomized budesonide in children with acute laryngeal-bronchitis has high clinical curative effect, the treatment course of patients is obviously shortened, the condition is recovered quickly and the clinical effect is better.